Heritage, Apotex plan to pay $49.1 million to settle drug pricing scheme allegations

Two pharmaceutical companies will pay $49.1 million to resolve allegations that they inflated prices, reduced competition and restricted access to generic drugs, Attorney General Kwame Raoul said Thursday.